605 related articles for article (PubMed ID: 32818519)
1. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.
Viswanathan U; Mani N; Hu Z; Ban H; Du Y; Hu J; Chang J; Guo JT
Antiviral Res; 2020 Oct; 182():104917. PubMed ID: 32818519
[TBL] [Abstract][Full Text] [Related]
2. Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators.
Luo Y; Cheng J; Hu Z; Ban H; Wu S; Hwang N; Kulp J; Li Y; Du Y; Chang J; Viswanathan U; Guo JT
Antiviral Res; 2021 Jul; 191():105080. PubMed ID: 33933516
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors.
Zhang X; Cheng J; Ma J; Hu Z; Wu S; Hwang N; Kulp J; Du Y; Guo JT; Chang J
ACS Infect Dis; 2019 May; 5(5):759-768. PubMed ID: 30525438
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation.
Zhao Q; Hu Z; Cheng J; Wu S; Luo Y; Chang J; Hu J; Guo JT
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669831
[TBL] [Abstract][Full Text] [Related]
5. HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.
Guo F; Zhao Q; Sheraz M; Cheng J; Qi Y; Su Q; Cuconati A; Wei L; Du Y; Li W; Chang J; Guo JT
PLoS Pathog; 2017 Sep; 13(9):e1006658. PubMed ID: 28945802
[TBL] [Abstract][Full Text] [Related]
6. Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis.
Liu H; Cheng J; Viswanathan U; Chang J; Lu F; Guo JT
PLoS Pathog; 2021 Nov; 17(11):e1010057. PubMed ID: 34752483
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
[TBL] [Abstract][Full Text] [Related]
8. A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.
Ko C; Bester R; Zhou X; Xu Z; Blossey C; Sacherl J; Vondran FWR; Gao L; Protzer U
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658963
[TBL] [Abstract][Full Text] [Related]
9. Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals.
Ruan L; Hadden JA; Zlotnick A
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089690
[TBL] [Abstract][Full Text] [Related]
10. CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging.
Wu S; Luo Y; Viswanathan U; Kulp J; Cheng J; Hu Z; Xu Q; Zhou Y; Gong GZ; Chang J; Li Y; Guo JT
Antiviral Res; 2018 Nov; 159():1-12. PubMed ID: 30201396
[TBL] [Abstract][Full Text] [Related]
11. Core Protein-Directed Antivirals and Importin β Can Synergistically Disrupt Hepatitis B Virus Capsids.
Kim C; Barnes LF; Schlicksup CJ; Patterson AJ; Bothner B; Jarrold MF; Wang CJ; Zlotnick A
J Virol; 2022 Jan; 96(2):e0139521. PubMed ID: 34705562
[TBL] [Abstract][Full Text] [Related]
12. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket.
Venkatakrishnan B; Katen SP; Francis S; Chirapu S; Finn MG; Zlotnick A
J Virol; 2016 Apr; 90(8):3994-4004. PubMed ID: 26842475
[TBL] [Abstract][Full Text] [Related]
14. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.
Huber AD; Pineda DL; Liu D; Boschert KN; Gres AT; Wolf JJ; Coonrod EM; Tang J; Laughlin TG; Yang Q; Puray-Chavez MN; Ji J; Singh K; Kirby KA; Wang Z; Sarafianos SG
ACS Infect Dis; 2019 May; 5(5):750-758. PubMed ID: 30582687
[TBL] [Abstract][Full Text] [Related]
15. Use of a Fluorescent Analogue of a HBV Core Protein-Directed Drug To Interrogate an Antiviral Mechanism.
Nair S; Li L; Francis S; Turner WW; VanNieuwenhze M; Zlotnick A
J Am Chem Soc; 2018 Nov; 140(45):15261-15269. PubMed ID: 30375863
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
[TBL] [Abstract][Full Text] [Related]
17. Identification of Compounds Targeting Hepatitis B Virus Core Protein Dimerization through a Split Luciferase Complementation Assay.
Wei XF; Gan CY; Cui J; Luo YY; Cai XF; Yuan Y; Shen J; Li ZY; Zhang WL; Long QX; Hu Y; Chen J; Tang N; Guo H; Huang AL; Hu JL
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224531
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B core protein as a therapeutic target.
Mak LY; Wong DK; Seto WK; Lai CL; Yuen MF
Expert Opin Ther Targets; 2017 Dec; 21(12):1153-1159. PubMed ID: 29065733
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.
Yang L; Liu F; Tong X; Hoffmann D; Zuo J; Lu M
ACS Infect Dis; 2019 May; 5(5):713-724. PubMed ID: 30896149
[TBL] [Abstract][Full Text] [Related]
20. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
